eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2005, Volume 1, Issue 2 : 155-152 doi: ijmmas.2005.155.159
Research Article
Pro-Mitosis as Selective Neuronal Apoptosis in Amyotrophic Lateral Sclerosis
Published
June 30, 2005
Abstract

It is perhaps significant that any attempt at responsive mitotic activity on the part of neurons as permanent phenotypes might result in injury and loss of cells. Programmed cell death might inherently constitute a component system at promitosis that involves activity on the part of the neuron to enter the cell cycle. It might be in terms of reactivity to inflammation, to trophic factor lack, to ischemia, or to the generation of and exposure to, numerous or varied toxins, that neurons of the anterior spinal horn, brain stem and precentral motor cortex would evolve as promitosis or as induced attempts at mitosis. Promitosis would constitute a susceptibility to cell death in the evolving exposure and development of cell cyclical activity that stresses and damages permanent phenotypic attributes of the neuron. A reactivity on the part of a neuron of specific physiologic category or subclass in amyotrophic lateral sclerosis would induce persistent cell loss that is characterized as aborted cell cyclical activity and as subsequent programmed cell death. Superoxide dismutase activity and its mutant forms would highlight such susceptibility to evolving neuronal injury and stress that is generated as both induced promitosis and as subsequent programmed cell death in the course of repeated attempts at entry into the cell cycle.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Percutaneous Balloon Angioplasty as First-Line Therapy in Low-Income Patients
31-34
Impact of Dual Antiplatelet Therapy Duration on Post-PCI Outcomes
11-14
Impact of Emergency PCI Protocols During Off-Hours: A Clinical Outcome Analysis
35-38
PCI Outcomes in Patients With Chronic Total Occlusion
14-17
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.